C56

Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis, 1st Edition

This document provides background information on mechanisms of hemolysis, icterus, lipemia/turbidity (HIL) interference; intended usefulness of HIL indices; establishment of HIL alert indices; availability of automated HIL detection systems; and interpretation, strengths, limitations, and verification of HIL indices in the clinical laboratory. 

Member Price: as low as $42.00

Nonmember Price: $140.00
Log in to see your price and add to cart

Publication Details

Chairholder: Merle B. Smith, MBA, MS, MT(ASCP)

Date of Publication: July 13, 2012

ISBN Number: 1-56238-799-5

Order Code PDF: C56AE

Order Code Print: C56A

Edition: First

Pages: 64

C56 Additional Details

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the document available for its informational content.